Sign inGet started

Jenkins John Kenneth

Insider CIK 1742557 · CRBP Director · PRVB Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRBP Corbus Pharmaceuticals Hol S Sale2026-06-102026-06-114,800$7.91 $38.0K3,833SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2026-05-192026-05-2112,300— $012,300SEC↗
CRBP Corbus Pharmaceuticals Hol A Award2026-05-192026-05-213,800— $08,633SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2025-05-302025-06-0216,000— $016,000SEC↗
CRBP Corbus Pharmaceuticals Hol S Sale2025-05-302025-06-022,783$7.35 $20.5K33SEC↗
CRBP Corbus Pharmaceuticals Hol A Award2025-05-302025-06-024,800— $04,833SEC↗
CRBP Corbus Pharmaceuticals Hol A Award2024-05-302024-06-032,783— $02,816SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2024-05-162024-05-202,783— $02,783SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2023-05-182023-05-225,300— $05,300SEC↗
PRVB Provention Bio, Inc. D To issuer deriv2023-04-272023-04-27128,981— $00SEC↗
PRVB Provention Bio, Inc. D To issuer deriv2023-04-272023-04-2733,000— $00SEC↗
PRVB Provention Bio, Inc. D To issuer deriv2023-04-272023-04-2723,000— $00SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2022-05-182022-05-1979,600— $079,600SEC↗
PRVB Provention Bio, Inc. A Award deriv2022-05-172022-05-1833,000— $033,000SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2021-06-172021-06-1758,200— $058,200SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2021-06-172021-06-1758,200— $058,200SEC↗
PRVB Provention Bio, Inc. A Award deriv2021-05-122021-05-1423,000— $023,000SEC↗
PRVB Provention Bio, Inc. A Award deriv2020-08-102020-08-11128,981— $0128,981SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2020-05-202020-05-2240,500— $040,500SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2019-05-222019-06-2833,300— $033,300SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2019-03-152019-03-151,000$6.98 $7.0K1,000SEC↗
CRBP Corbus Pharmaceuticals Hol A Award deriv2018-06-052018-06-0668,000— $068,000SEC↗